Sai is a Professor at ETH Zurich in the Department of Biosystems Science and Engineering since 2012. He also serves as the Vice-Director of the Botnar Research Centre for Child Health, focusing on the development of cutting-edge technologies for pediatric patients globally.
His academic research is dedicated to the emerging field of systems, synthetic and computational immunology. Based on his research, he co-founded the biotech companies deepCDR Biologics and Engimmune Therapeutics. deepCDR was acquired by Alloy Therapeutics in December 2021 due to its bioinformatics and machine learning expertise.
Sai studied biomedical engineering at the Northwestern University, USA, and obtained his PhD from EPFL Lausanne.
Current role